Literature DB >> 21171881

Overview of antimicrobial therapy in intensive care units.

Julien Textoris1, Sandrine Wiramus, Claude Martin, Marc Leone.   

Abstract

In the management of a patient with severe sepsis, it is important to suspect the infection early, to collect samples immediately after diagnosis and to promptly initiate a broad-spectrum antibiotic treatment. The choice of this empirical antimicrobial therapy should be based on host characteristics, site of infection, local ecology and pharmacokinetics/pharmacodynamics of antibiotics. In severe infection, guidelines recommend the use of a combination of antibiotics. After results of cultures are obtained, treatment should be re-evaluated to either de-escalate or escalate the antibiotic prescription. This is associated with optimal costs, decreased incidence of superinfection and minimal development of antimicrobial resistance. All these steps should rely on written protocols, and the compliance to these protocols should be continuously monitored in order to detect violations and implement corrective procedures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21171881     DOI: 10.1586/eri.10.147

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  5 in total

1.  How to approach and treat VAP in ICU patients.

Authors:  Bárbara Borgatta; Jordi Rello
Journal:  BMC Infect Dis       Date:  2014-04-30       Impact factor: 3.090

2.  Agreement on the prescription of antimicrobial drugs.

Authors:  Eduardo Casaroto; Alexandre R Marra; Thiago Zinsly Sampaio Camargo; Ana Rita Araújo de Souza; Carlos Eduardo Saldanha de Almeida; Elizia Piassi Pedroti; Elivane da Silva Victor; Oscar Fernando Pavão dos Santos; Michael B Edmond; Alexandre Holthausen Campos
Journal:  BMC Infect Dis       Date:  2015-06-30       Impact factor: 3.090

3.  How to measure the impacts of antibiotic resistance and antibiotic development on empiric therapy: new composite indices.

Authors:  Josie S Hughes; Amy Hurford; Rita L Finley; David M Patrick; Jianhong Wu; Andrew M Morris
Journal:  BMJ Open       Date:  2016-12-16       Impact factor: 2.692

4.  Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients.

Authors:  Patricia Cornejo-Juárez; Diana Vilar-Compte; Alejandro García-Horton; Marco López-Velázquez; Silvio Ñamendys-Silva; Patricia Volkow-Fernández
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

5.  Sepsis, Cytokine Storms, and Immunopathology: The Divide between Neonates and Adults.

Authors:  Kara G Greenfield; Vladimir P Badovinac; Thomas S Griffith; Kathryn A Knoop
Journal:  Immunohorizons       Date:  2021-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.